Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 12330  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
Read this article

 


    Article Cited by others

DRUG REVIEW

Bedaquiline: A novel antitubercular drug for multidrug-resistant tuberculosis

Nagabushan H, Roopadevi H S

Year : 2014| Volume: 60| Issue : 3 | Page no: 300-302

   This article has been cited by
 
1 Efficacy and safety of bedaquiline and delamanid in the treatment of drug-resistant tuberculosis in adults: A systematic review and meta-analysis
Syeda Hoorulain Ahmed, Hoorain Haider, Abdul Moeed, Aysal Mahmood, Nasir Shivani, Syed Hasan Shuja, Javeria Hayat, Bushra Jamil, Razia Fatima
Indian Journal of Tuberculosis. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 QSAR Studies, Molecular Docking, Molecular Dynamics, Synthesis, and Biological Evaluation of Novel Quinolinone-Based Thiosemicarbazones against Mycobacterium tuberculosis
Jhesua Valencia, Vivian Rubio, Gloria Puerto, Luisa Vasquez, Anthony Bernal, José R. Mora, Sebastian A. Cuesta, José Luis Paz, Braulio Insuasty, Rodrigo Abonia, Jairo Quiroga, Alberto Insuasty, Andres Coneo, Oscar Vidal, Edgar Márquez, Daniel Insuasty
Antibiotics. 2022; 12(1): 61
[Pubmed]  [Google Scholar] [DOI]
3 Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Pulmonary Tuberculosis
Anuradha T Deshkar, Prashant A Shirure
Cureus. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Adverse effects of bedaquiline in patients with extensively drug-resistant tuberculosis
Razia Gaida, Ilse Truter, Charles A. Peters
Southern African Journal of Infectious Diseases. 2020; 35(1)
[Pubmed]  [Google Scholar] [DOI]
5 Bedaquiline: A Mini Review
Nandhini Saravanabavan, Padmavathi Shanmuganathan, Manimekalai Kumarappan
Annals of SBV. 2020; 8(1): 2
[Pubmed]  [Google Scholar] [DOI]
6 Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents
Pavan K. Bangalore, Siva K. Vagolu, Rakesh K. Bollikanda, Dileep K. Veeragoni, Pallavi C. Choudante, Sunil Misra, Dharmarajan Sriram, Balasubramanian Sridhar, Srinivas Kantevari
Journal of Natural Products. 2020; 83(1): 26
[Pubmed]  [Google Scholar] [DOI]
7 A Multi-Pronged Computational Pipeline for Prioritizing Drug Target Strategies for Latent Tuberculosis
Ushashi Banerjee, Santhosh Sankar, Amit Singh, Nagasuma Chandra
Frontiers in Chemistry. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
8 Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy
Caroline M. Pule,Samantha L. Sampson,Robin M. Warren,Philippa A. Black,Paul D. van Helden,Tommie C. Victor,Gail E. Louw
Journal of Antimicrobial Chemotherapy. 2016; 71(1): 17
[Pubmed]  [Google Scholar] [DOI]
9 Identification of an anti-TB compound targeting the tyrosyl-tRNA synthetase
Ningyu Zhu,Yuan Lin,Dongsheng Li,Nana Gao,Chang Liu,Xuefu You,Jiandong Jiang,Wei Jiang,Shuyi Si
Journal of Antimicrobial Chemotherapy. 2015; 70(8): 2287
[Pubmed]  [Google Scholar] [DOI]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow